This report highlights how rare genetic disorders, oncology, and improvements in RNA delivery platforms (e.g., lipid nanoparticles) are fueling the rapid growth of RNA-based therapies. https://finance.yahoo.com/news/rna-based-therapies-market-reach-151600770.html